PTT-4256
Pathios Therapeutics
['thio']
#pathiostherapeutics unveils #ptt4256, a highly potent and selective inhibitor of #gpr65, in presentation at #aacr23 
Follow top-line development in the oncology commercial domain through our award winning intelligence service, 1stOncology.